Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thalmann

Showing results (31-40 of 307) with videos related to

Pageof 31
Sort By:
Der Urologe. Ausg. A|January 17, 2019
[Instillation therapies for urothelial carcinoma of the upper urinary tract]P Bosshard, G N Thalmann, B Roth
Der Urologe. Ausg. A|April 14, 2017
[Therapeutic management of blunt testicular trauma]B Lyttwin, F Moltzahn, G N Thalmann
Journal of Clinical Pathology|June 23, 2011
MMP-2 and MMP-9 in lymph-node-positive bladder cancerRoland Seiler, George N Thalmann, Achim Fleischmann
Research and Reports in Urology|January 9, 2014
Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institutionRoland Seiler, George N Thalmann, Pascal Zehnder
Therapeutische Umschau. Revue Therapeutique|March 7, 2006
[Radical prostatectomy in the treatment of organ confined prostate cancer]M Schumacher, G N Thalmann, U E Studer
World Journal of Urology|November 21, 2015
Open radical cystectomy: still the gold standard for muscle invasive bladder cancerBernhard Kiss, Fiona C Burkhard, George N Thalmann
American Journal of Clinical and Experimental Urology|July 25, 2022
Role of prostate and bone stromal cells on prostate cancer progressionSofia Karkampouna, Marianna Kruithof-de Julio, George N Thalmann
International Journal of Urology : Official Journal of the Japanese Urological Association|October 24, 2014
Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?Bernhard Kiss, Silvia Schneider, George N Thalmann, et al.
Therapeutische Umschau. Revue Therapeutique|March 7, 2006
[Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH)]R M Müller, G N Thalmann, U E Studer
Prostate Cancer and Prostatic Diseases|May 12, 2016
MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factorV Genitsch, I Zlobec, G N Thalmann, et al.
Pageof 31

Showing results (31-40 of 307) with videos related to

Sort By:
Pageof 31
Der Urologe. Ausg. A|January 17, 2019
[Instillation therapies for urothelial carcinoma of the upper urinary tract]P Bosshard, G N Thalmann, B Roth
Der Urologe. Ausg. A|April 14, 2017
[Therapeutic management of blunt testicular trauma]B Lyttwin, F Moltzahn, G N Thalmann
Journal of Clinical Pathology|June 23, 2011
MMP-2 and MMP-9 in lymph-node-positive bladder cancerRoland Seiler, George N Thalmann, Achim Fleischmann
Research and Reports in Urology|January 9, 2014
Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institutionRoland Seiler, George N Thalmann, Pascal Zehnder
Therapeutische Umschau. Revue Therapeutique|March 7, 2006
[Radical prostatectomy in the treatment of organ confined prostate cancer]M Schumacher, G N Thalmann, U E Studer
World Journal of Urology|November 21, 2015
Open radical cystectomy: still the gold standard for muscle invasive bladder cancerBernhard Kiss, Fiona C Burkhard, George N Thalmann
American Journal of Clinical and Experimental Urology|July 25, 2022
Role of prostate and bone stromal cells on prostate cancer progressionSofia Karkampouna, Marianna Kruithof-de Julio, George N Thalmann
International Journal of Urology : Official Journal of the Japanese Urological Association|October 24, 2014
Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?Bernhard Kiss, Silvia Schneider, George N Thalmann, et al.
Therapeutische Umschau. Revue Therapeutique|March 7, 2006
[Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH)]R M Müller, G N Thalmann, U E Studer
Prostate Cancer and Prostatic Diseases|May 12, 2016
MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factorV Genitsch, I Zlobec, G N Thalmann, et al.
Pageof 31